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Numerical simulations of the cardiovascular system are particularly important in scenarios where it is difficult to 
experiment different weightlessness exposure conditions. Technological advances in terms of computational power 
in the last years, and improvement of algorithms have recently made these techniques more reliable. We report in 
this paper results from extensive simulations undertaken in a computing facility in our University (UPC 
BarcelonaTech) aimed at evaluate the risks involved in a long-term exposure to reduced gravity loads for a very 
extensive range of possible mission scenarios. The simulation allows to introduce different levels of exposure to 
hypo or hypergravity, and analyze the consequences on relevant figures of cardiovascular deconditioning, such as 
heart rate, mean stroke volume or vascular resistance. Neurological or thermic stress or aerobic exercise can also be 
applied in order to better emulate a realistic long-term space mission comprising, for example, Extra Vehicular 
Activities (EVA) or physical exercise as countermeasures. Gender differences have also been studied, with 
significant different recommendations given as outcomes of the simulation, for both men and female astronauts. Our 
model is based on the previous works form Melchier et al. or Heldt et al. who described in analytical terms the 
process of orthostatic intolerance due to gravity alterations being applied on a human subject. We incorporated these 
Runge-Kutta equations by using Matlab® and Simulink® software. Results from these models were validated in 
parabolic flight. We later developed this model to take into account all control system parts involved in the human 
cardiovascular system, and we finally achieved an electrical-like control model in which we could easily measure the 
output of the system (vascular resistance, blood volume etc.) as a means to assess the level of cardiovascular 
deconditioning. Step-by-step changes of gravity and thermal stress were later applied, as well as other real-like 
mission inputs. Different scenarios of Moon and Mars exploration missions are considered, and their associated risks 
are quantified. The more relevant results are provided, including the finding that the vascular resistance 
deconditioning appears to be alike in both microgravity and the reduced gravity at the level of the Moon; which 
raises concerns for a successful manned Mars mission scenario. This work may contribute to a better understanding 
of the underlying processes involved for both women in man adaptation to long-term microgravity, and shows the 
potential of such numerical simulations for designing manned mission scenarios. 
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Numerical simulations of the cardiovascular and other 
physiological systems are particularly important in 
scenarios where it is difficult to experiment 
weightlessness exposure conditions, and long-term 
spaceflight is an area where it may apply.  
Technological advances in terms of computational 
power and improvement of algorithms have improved in 
the last years, becoming these techniques more feasible. 
    One of the major concerns for both sort- and long-
term spaceflight is the phenomenon of cardio-vascular 
deconditioning. The cardio-vascular system has as a 
primary function to circulate blood through the body. 
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Although responses of the cardio-vascular system to 
microgravity seem to have been relatively free of major 
threats to wellbeing and performance during flight, 
problems as orthostatic hypotension and diminished 
exercise capacity are commonly observed after return to 
Earth.  
    Regarding long-term effects, the expose to 
microgravity beyond nine months on the cardio-vascular 
system are entirely unknown. This is of great concern, 
because they may involve the emergence of irreversible 
alterations in cardio-pulmonary function. There is also 
concern that there may be a loss of cardiac mass during 
prolonged microgravity exposure. The worst-case of a 
major incapacitating event for International Space 
Station (ISS) crews over a one-year period is estimated 
to be 1% per person per year [1]. 
   Research studies have focused on understanding the 
effects of spaceflight on the cardio-vascular system by 
studying heart rate, blood vessel performance, blood 
pressure, and blood volume during spaceflight and upon 
return to Earth. One goal of these studies have been to 
determine precisely when fluid shifts occur, because 
they are believed to be the precursor of other 
physiologic changes which take place in a microgravity 
environment.  
    Some studies performed on six astronauts before and 
after long-duration (129-190 days) spaceflights revealed 
that orthostatic intolerance in even more severe after 
long-duration than after short-duration flights. Five in 
six astronauts became pre- syncopal during tilt testing 
after long-duration flights, whereas just one had become 
pre-syncopal during stand testing after short-duration 
flights [2]. 
    Diminished vascular function, for example, is a 
primary cardiovascular risk of spaceflight. Astronauts 
have experienced presyncopal episodes on landing day 
as a result of lower peripheral vascular resistance [3].  
    In order to minimize these potential hazards, a 
number of potential countermeasures have been studied 
and put into practice. Physical exercise is well-known 
for its capacity to reduce these adaptations. A number of 
protocols have been carried out on board to improve 
physical health of cosmonauts and astronauts [4].  
    On the other hand, it has been reported a significant 
reduction in the percent of the whole blood that is 
comprised of red blood cells (hematocrit) in some 
astronauts. This reduction is what is often referred as 
space anemia.  Overabundance of fluids in the upper 
part of the body causes the kidneys to remove this 
excess fluid, part of which is plasma. Then, the 
reduction in plasma volume causes an over-abundance 
of oxygen-carrying capability. That would reduce the 
production of erythropoietin and consequently decrease 
red blood cell production. As muscles lose mass in 
space they will require less oxygen and the process is 
reinforced.  It is also possible that too much oxygen-
carrying capacity in the blood may cause an increase in 
the destruction rate of red blood cells. Finally, as 
astronauts lose calcium in their bones, the structure and 
function of the bone and its marrow may change and 
may result in a decrease in red blood cell production.  
    Space anemia can be characterized by decreased Red 
Blood Cell (RBC) mass and has been reported from the 
early days of spaceflight. Comprehensive experiments 
by Alfrey et al. conducted aboard missions SLS-1 and 
SLS-2 provided an understanding of the mechanisms 
underlying spaceflight anemia [5, 6]. Therefore anemia 
appears to be a self-limiting and adaptive response to 
fluid shifts associated with microgravity. 
     Although a number of studies provide a well-
stablished model of hematological changes in short-term 
spaceflights, more research is needed in terms of long-
term behaviour of the entire cardiovascular system.  As 
human and rodent model individuals have few 
opportunities to provide refinement into previous short-
term models, numerical simulations arise as a new line 
of research. Long-term simulations may also preview 
any possible outcomes which are difficult to forecast in 
real models.  
   Studies of Artificial Gravity as a countermeasure to 
the cardiovascular deconditioning [7] have led to 
experimental results that have validated numerical 
cardiovascular models [8], showing the potential of this 
computational approach. 
    Overall, there are a number of current efforts [9, 10] 
which take into account the advantages of digital 
simulations, this paper being one more contribution to 
them.  
 
2. Numerical Model 
 
A number of numerical models have proposed in order 
to understand the response of the cardiovascular system 
to microgravity and return to Earth.  A review of the 
early models that account for orthostatic intolerance can 
be found in the work of Melchier et al [11]. Modeling 
the response to gravity can be illustrated with the work 
of Heldt et al. [12]. A single cardiovascular model is 
used to simulate the steady-state and transient response 
to ground-based tests. The hemodynamic model is 
mathematically formulated in terms of an electrical- 
analog model in which inertial effects are neglected. 
Their entire model was described by 12 first-order 
differential equations. An adaptive step-size fourth-
order Runge-Kutta integration routine was used to solve 
the system of differential equations numerically.   
    Based on these previous models, a parametric study 
was extended in order to see how different degrees of 
gravity exposure may affect the output parameters of the 
cardiovascular system.   
    A standard physiological control system was 
simulated with standard simulation tools (Matlab®, 
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Simulink®.  Then their parametric dependence with 
gravity was studied with a number of different trials and 
scenarios. A number of electrical-like modules were 
added to the previous model in order to assess the 
behaviour of spleen and bone marrow, and other organs 
as well.   
    We applied different acute inputs in order to simulate 
external perturbations to a steady-state scenario in low 
gravity. Countermeasures were taken in account as 
patterns applied along long duration terms.  Further 
accounts of extreme external temperatures and 
exhaustion were applied to simulate Extra Vehicular 
Activities (EVA) in different conditions.  
 
3. Numerical analysis and Results 
 
3.1 Protocols and Results 
 
The model was developed and validated comparing 
results with available published data as we found out in 
our previous communication [10]. Therefore, a first 
series of trials were conducted in standard gravity to 
assess the reliability of the model. Heart rate, stroke 
volume and main arterial pressure were assessed with 
no deviation with clinical standard data on ground.  
    Then a further analysis was undertaken in order to see 
the influence of the g parameter on the output results. 
We conducted a number of simulations with different 
gravity factors including 1/3, 1/6, 1/100, 1/1000, 1 µg 
and zero-g, in order to get a wide range of results.  A 
transient acute response was found when applying the 
new steady gravity input.  No significant differences 
within the steady-state compared to one g simulations 
were found if the simulated exposure time was less than 
four days. However, we found that when gravity is less 
than 23% of ground and time and exposure time longer 
than four days, significant differences were found.  
    We applied a number of different simulations with a 
pulmonary system module attached to the original 
control model, which is mainly a capacitor-resistance 
coupling.  Gravity was applied from zero-g to one-g in 
0.01 steps. Significant differences (p<0.05) in vascular 
resistance measured in the appropiate electrical model 
were found for gravity less than 0.43 in sixteen days. A 
full series of simulation was induced up to 2-years 
extended time.  When taken into account risk 
probability, it was clearly above 1% of major 
malfunction probability in the physiological system at 
above 69 days, with g being less than 0.01.  This risk 
was slightly raised when the simulated mission was 
extended up to two years. 
    Physical exercise was applied as a pattern of aerobic 
exercise, thirty minutes every day for every mission.  
We saw how the estimated overall risk was slightly 
reduced only for missions longer than 134+/- 12 days 
(p<0.05). When a final step of one-g was applied to 
simulate transition to normal gravity at the end of the 
mission, risk of a distress due to hypovolemia was 
indeed reduced up to 19+/-4 % showing better results as 
elapsed time in simulation was higher.  
   Thermal distress was applied as well as strong 
exercise to simulate EVAs for a time not longer than 8 
hours, three times a week. The risk of an acute 
physiological disfunction was increased but in terms of 
a healthy subject scenario, was not a major concern as it 
not added more than 1.5% risk to the initial values. A 
series of tests were conducted for longer missions 
showing that this pattern was not jeopardizing an entire 
mission. 
 
3.2 Gender differences  
 
All Physiological differences are a matter of concern 
regarding long-term microgravity effects on the 
cardiovascular system. Women seem to have greater 
sensitivity to orthostatic intolerance than men [13]. 
Some countermeasures have been proposed for both 
men and women, such as Artificial Gravity (AG). 
Goswami et al. [14] found that after an individualized 
centrifugation training was applied, both men and 
women showed an increase in Orthostatic Tolerance 
Limit (OTL) after AG was applied.  
 We studied from our model which was the response 
of men vs female in terms of aerobic exercise response 
according to the patterns presented before.  Differences 
in the physiological of men vs women were 
parametrized according to current findings accepted in 
the literature. Muscular mass formation was specially 
taken into account. 
It was found (Fig. 1) that after more than 6 months 
in microgravity (g<0.1) exposure and an aerobic 
exercise pattern applied, the overall risk reduction of a 
major cardiovascular disfunction was reinforced in 




Fig. 1. Gender differences in risk reduction after an 
applied aerobic exercise pattern. 
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The difference was statistical significant in the 
simulation when exposure to microgravity was 
simulated for more than 210 days, resulting in a total 
1.5+/- 0.2 risk reduction for female, and 1.1+/- 0.1 in 
men. This result was found to be nearly constant for 9 
months of exposure or more, in concordance with 
previous results. 
 
4. Moon and Mars missions analysis  
 
Space radiation is the most limiting factor for 
manned spaceflight. Current estimations establish 
between 3 and 5% as Permission Exposure Limits 
(PEL) of added risk of putting a mission in jeopardy, as 
an acceptable one [15]. Space radiation is not 
considered in this model, therefore we can estimate only 
weightlessness effects on the total risks. Although these 
particular effects are not the primary concern, it is also 
worth considering to evaluate these risks. By using the 
model, we can consider steady conditions, with no 
EVAs, a pattern of aerobatic exercise during the Mars 
mission, and no additional considerations regarding 
other health hazards. 
After a standard Moon and Mars missions were 
considered, additional risks were estimated as 
following:  
 
Moon Mission    (+/- 0.01%) 
7 days stay ---    0.04% 
15 days stay –    0.045%-  
30 days stay –     0.060% 
60 days stay        0.071% 
75 days stay        0.083% 
100 days stay      0.10% 
300 days stay      0.18% 
500 days stay       0.43% 
1000 days stay     0.74% 
5000 days stay     2.45% 
 
 
Mars Mission    (+/- 0.05%) 
 
Elapsed time on Mars: 
3 months       0.40% 
6 months       0.60% 
9 months –    0.80%  
15 months -   1.20% 
18 months     1.45% 
27 months     1.65% 
54 months     3.15% 
 
 
The results from the model suggest that added risks 
are within safety limits, but not negligible. 
 
 
5. Conclusions  
 
    A system to simulate the physiological response of 
the body to the long-term influence of microgravity has 
been developed. The system is capable to focus on the 
behaviour of a concrete organ in the body as well as to 
assess the risks of a major physiological malfunction.  
Different inputs and input patterns along elapsed 
mission time can be applied to simulate 
countermeasures such as physical exercise.  
    Numerical modelling has proven to be a valuable tool 
to predict possible risks of developing organ and 
systems malfunctions in spaceflight.  
    The system has been validated with the available 
published data and has been used to assess risks coming 
from the blood-forming organs, or reduced vascular 
function when coming back to Earth after spaceflight.  
    With the limitations exposed of this model, we 
conclude that risks of a major physiological malfunction 
are increased in scenarios such as an EVA, but totally 
controlled and not a major concern when conducted in 
long-term missions. This is in accordance to previous 
in-flight experiences with available data.   
    We also conclude that, when a pattern of physical 
exercise is applied as a countermeasure the risk is 
decreased as the physiological system responds better as 
decondition is diminished, according to well-known 
previous experiences.   
    Estimations from different scenarios of manned 
missions to the Moon and Mars have been considered, 
suggesting that microgravity exposure is a secondary 
health factor risk, after space radiation.  
    This is but one more numerical simulation that adds 
itself to the endeavour for a total understanding of what 
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